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The transglutaminase-mediated insertion of putrescine into casein was inhibited competitively by cy- 
difiuoromethylornithine (rw-DFMO), an enzyme-activated irreversible inhibitor of ornithine decarboxylase. 
Preincubation of the amine acceptor (casein) or the enzyme itself with the inhibitor did not affect enzyme 
activity. cu-DFMO is a poorer substrate for transglutaminase (Km = 2.10 mM) than putrescine (iu, = 
0.17 mM). The inhibitory effect was also found with fibronectin as amine acceptor. 
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1. I~RODUCTION 
There are abundant reports in the literature 
showing that polyamines are essential for cell 
growth and proliferation [ 1,2). This conclusion 
was established on the one hand from experiments 
in which polyamine levels were measured at 
various intervals after a growth stimulus [3] and on 
the other, from results obtained with a-DFMO, an 
enzyme-activated irreversible inhibitor of ornithine 
decarboxylase [4,5]. With this inhibitor, cell 
growth could be restored by the subsequent addi- 
tion of putrescine [6,7]. 
The large number of intracellular enzymic reac- 
tions which are modulated by free polyamines 
(DNA, RNA, fatty acid and protein synthesis, ox- 
idative phosphorylation) has made it difficult to 
ascribe to any one particular enzyme the role of the 
primary target of polyamine depletion. Further, 
there exist enzyme systems such as the trans- 
glut~inases which are capable of covalently in- 
serting polyamines into the amide group of 
glutamine residues in proteins [8,9]. The latter fact 
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raised the question whether the levels of protein- 
bound polyamines (such as putrescine) are affected 
by the addition of tu-DFMO to cells either by the 
direct action of a-DFMO on transglutaminases or
indirectly by reducing putrescine availability. If 
there is already evidence for the relationship be- 
tween cadaverine availability and cadaverine bind- 
ing (as its dansyl derivate) in cells in culture [lo], 
to our knowledge, no information is available on 
the effect of a-DFMO on transglutaminase activi- 
ty. To investigate this, the experiments described 
here were carried out. 
2. MATERIALS AND METHODS 
2.1. Materials 
[ 14C]Putrescine dihydrochloride f [ 1 ,4-14C]tetra- 
methylenediamine dihydrochloride, spec. act. 109 
Ci/mol ) and a-[ 14C]DFM0 { DLlr-difluoro- 
methyl[5-14C]or~thine, spec. act. 56 Cilmol] 
were purchased from the Radiochemical Center 
(Amersham, Bucks.) and [14C]ornithine monohy- 
drochloride { DL-[l-14C]ornithine monohydro- 
chloride; spec. act. 50.3 Ci/mol j from New 
England Nuclear (Boston, MA). Putrescine dihy- 
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drochloride and casein were obtained from Sigma 
(St Louis, MO), L-( + )-ornithine hydrochloride 
from Aldrich-Europe (Beerse, Belgium) and Pico- 
Fluor 30 from Packard Instrument Co. (Downers 
Grove, IL). (u-DFMO was a kind gift from Centre 
de Recherche Merrel Int. (Strasbourg, France). 
Transglutaminase was purified from guinea pig 
livers [l I]. One unit of transglutaminase cor- 
responds to the amount of enzyme capable of in- 
serting 100 pm01 putrescine into 20 pg casein for 
30 min at 37°C. 
2.2. Methods 
To experimental tubes containing 20 r(lg casein in 
30~1 buffer (see below) were added 25 pl 
(14C]putrescine (5&Zi/ml) at levels ranging from 
346 to 1046 KM (75-444 ,uM final concentration). 
To the mixture were added 20~1 (u-DFMO in 
amounts ranging from I to 25 mM (0.17-4.35 mM 
final concentration) or 20 pl ornithine in amounts 
ranging from 25 to 100 mM (4.35-17.40 mM final 
concentration) and 20 pl transglutaminase (10 
units). The reaction was initiated by the addition 
of calcium to a final concentration of 7 mM. All 
constituents of the reaction mixture were dissolved 
in 0.14 M NaCYO.01 M Tris-HCl (pH 7.5) and 
the volume was adjusted to 115 ~1 with the same 
buffer. 
Two types of control were performed: one con- 
tained all constituents except casein, the other all 
reagents except cy-DFMO or ornithine, which were 
replaced by buffer. 
After incubation at 37°C for 30 min with gentle 
shaking, 20 ~1 incubation mixture were spotted on- 
to a Whatman 3MM filter paper disc pre-soaked 
with 100~1 EDTA (100 mM). The filters were im- 
mediately immersed in 10% ice-cold trichloro- 
acetic acid. Free [‘4C]putrescine was removed by 3 
repeated washings (20 min each at 4°C with shak- 
ing) with 10% trichloroacetic acid containing 
0.01 M putrescine and finally with 95% ethanol 
(5 min). The filters were then dried, and the 
remaining covalently bound radioactivity was 
measured in a Packard Liquid Scintillation Spec- 
trometer BPLD (efficiency for 14C of 85%) with 
5 ml Pica-Fluor 30. The number of nmol putres- 
tine bound/30 min per 20pg casein was deter- 
mined from the specific radioactivity of putrescine 
as follows: 
222 
(Transglutaminase + [‘4C]putrescine + casein + 
Ca2+) - (transglutaminase + [r4C]putrescine + 
buffer + Ca’+) 
When [14C]ornithine or tw-[r4C]DFM0 was used 
as substrate, the experimental procedure was the 
same as that described above for [14C]putrescine 
with the following modifications: 
(i) [‘4CfPutrescine was replaced by 25 pl [‘4C]or- 
nithine (5 &i/ml) at levels ranging from 400 to 
21OOpM (87-456bM final concentration) or by 
25 ~1 cr-[t4C]DFM0 (20 &%‘ml) at levels ranging 
from 1860 to 4360,uM (400-950 ,uM final 
concentration). 
(ii) Unlabelled u-DFMO or ornithine was replaced 
by buffer. 
(iii) Filters were washed, respectively, in 0.01 M 
ornithine/lO% trichloroacetic acid and 0.01 M (Y- 
DFMO/lO~o trichioroacetic acid. 
All experiments were carried out in duplicate, 
and duplicates agreed within 5%. 
3. RESULTS 
3.1. Effecf of CY-DFMU on tru~~lutarn~~a~e- 
mediated insertion of putrescine into casein 
This was investigated as described in section 2 
with concentrations of a-DFMO ranging from 2 to 
30 mM in the presence of 23 mM putrescine. Or- 
nithine over a similar concentration range was used 
as control. It can be seen from fig.1 that 50% in- 
hibition was obtained with 2.6 mM cu-DFMO, 
whereas with ornithine an almost S-fold greater 
concentration (14.2 mM) is needed. 
3.2. (r-DFMO, a competitive inhibitor of 
transglutaminase 
This was assessed at 3 different concentrations 
of cu-DFMO: 3.3, 1.7 and 0.8 mM, and concentra- 
tions of putrescine ranging from 0.07 to 0.44 mM. 
It is apparent (fig.2) that (u-DFMO is a competitive 
inhibitor of transglutaminase which shows a K,, 
for putrescine of 0.17 mM and a I’,, of 
1.14 nmol putrescine bound/20 pg casein per 
30 min. This competitive inhibition can be an- 
nulled by increasing the amount of putrescine 
relative to that of a-DFMO. It decreases from 70% 
at a putrescine/cY-DFMO ratio of 0.02 to 4% at a 
ratio of 0.51. 
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Fig.1. Inhibition of the transglutaminase-mediated insertion of putrescine (23 mM) into casein by a-DFMO (m) or 
ornithine (m). Each point represents the average of duplicate determinations carried out as described in section 2, in 
two different experiments. 
Replotting the data of fig.2 in the form of a Dix- 
on plot (fig.3) determined the Ki to be 2.28 mM 
which is in good agreement with the calculated 
value of 2.31 mM. In the case of ornithine (fig.4), 
the Ki value was found to be 12.10 mM, a 5-fold 
increase. 
Transglutaminase is a two-substrate nzyme and 
is capable of interacting with the second substrate 
(the amine donor) only after the formation of an 
acyl enzyme complex with the first substrate (the 
amine acceptor) [8]. It was therefore possible that 
(Y-DFMO could inhibit the overall reaction by in- 
teracting with the amine acceptor or the enzyme 
itself. To investigate this, 20 pg casein and 10 units 
transglutaminase were preincubated individually 
for 30 min at 37°C with (Y-DFMO at 8 and 10 mM, 
E’ig.2. Lineweaver-Burk representation of the results of the transglutaminase (10 units)-mediated incorporation of 
putrescine (PUT) into casein (20 pg) in the absence of cu-DFMO (0) or in the presence of cu-DFMO at different 
concentrations: (A) 0.87 mM; (A) 1.74 mM; (0) 3.50 mM. Each point represents the average of duplicate 
determinations carried out as described in section 2, in two different experiments. 
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Fig.3. Dixon plot of the results obtained on adding increasing concentrations of cu-DFMO to a mixture of 
transglutaminase (10 units), casein (20 pg) and calcium (7 mM) in the presence of different concentrations of putrescine: 
(A) 75 ,uM, (A) 140pM, (0) 227 pM, (0) 444 PM. Experimental details as in text. Each point represents the average 
of duplicate determinations carried out in two different experiments. 
respectively. Control incubation mixtures contain- NaC110.01 M Tris-HCl (pH 7.5). Then a 50-,& ali- 
ed the same amounts of casein and trans- quot of casein preincubation mixture was added to 
glutaminase but without cu-DFMO. At the end of the normal reaction mixture containing [14C]- 
the preincubation, the contents of each preincuba- putrescine (12.5 CUSS nmol), calcium (7 mM 
tion mixture were dialysed against 0.14 M fina concentration) and 10 units transglutaminase 
*+ 
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Fig.4. Same as for fig.3, except that (u-DFMO was replaced by ornithine. 
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in a final volume of 115 pi. In the case of the trans- 
glutaminase preincubation mixture, a 40-~1 aliquot 
was added to an incubation mixture containing 
[14C]putrescine and calcium as described above, 
and casein at 20 pg. It is apparent (table 1) that LY- 
DFMO has no influence on the transglutaminase- 
mediated insertion of putrescine when prein- 
cubated alone with either casein or trans- 
glutaminase. 
Since transglutaminase has an absolute require- 
ment of calcium, a further control for trans- 
glutaminase was carried out by preincubating the 
enzyme in the presence of calcium with or without 
my-DFMO. There was no significant difference in 
the residual activity of transglutaminase incubated 
in the presence or absence of calcium and in the 
presence or absence of a-DFMO. 
It would therefore seem that inhibition of trans- 
glutaminase by a-DFMO required the simul- 
taneous presence of casein, transglutaminase, 
calcium, cu-DFMO and putrescine. 
In view of this, attempts were made to determine 
whether a-DFMO is a substrate of transgluta- 
minase. 
3.3. a-DFMO: an amine donor for transgluta- 
mina$e 
This was checked experimentally using cy- 
[‘4C]DFM0 as the amine donor and casein as the 
amine acceptor under the same experimental con- 
ditions as those used for [‘4C]putrescine. For com- 
Table 1 
Transglutaminase-mediated ns rtion of putrescine into 
casein after preincubation of casein (2Opg) alone or 
transglutaminase (10 units) alone for 30 min in the 
presence or absence of cu-DFMO 
- 
Composition of Putrescine insertion 
preincubation mixture (nmol bound/30 min 
per 208g casein) 
a-DFMO 
Casein + 
Transglutaminase + 
- 
Tr~sglutaminase + 
+ calcium - 
(7 mM) 
0.16 
0.17 
0.09 
0.10 
0.07 
0.06 
Results are the means of 2 experiments in duplicate 
Table 2 
Apparent K,,, and V,,, of the transglutaminase-mediated 
insertion of putrescine, ornithine and (r-DFMO into 
casein 
Amine donor kr, OnM) V max 
(nmol bound/30 min 
per 20pg casein) 
Putrescine 0.17 1.14 
Ornithine 1.35 0.53 
cu-DFMO 2.10 0.04 
Results are the means of 2 experiments in duplicate 
parative purposes [14C]ornithine was also tested as 
an amine donor. 
The results (table 2) show that ornithine and cy- 
DFMO are relatively poor substrates for trans- 
glutaminase compared to putrescine and this order 
of affinity was substantiated by V,,,,, values of 
0.04, 0.53 and 1.14 nmol bound/30 min per 20 pg 
casein, respectively, for cu-DFMO, ornithine and 
putrescine. 
4. DISCUSSION 
The only well documented effect of a-DFMO is 
the specific ‘suicide’ inhibition of ornithine decar- 
boxylase. Our results provide evidence that cy- 
DFMO is also a good competitive inhibitor of 
transglutaminase (fig.2). 
This inhibition was observed with putrescine as 
amine donor for an artificial amine acceptor, ca- 
sein (Km = 0.17 mM). 
The inhibition of transgiut~in~e by cu-DFMO 
was not limited to casein as amine acceptor but was 
also found when fibronectin, one of its natural 
substrates [12], was used. With this glycoprotein as 
amine acceptor, the Ki of a-DFMO for trans- 
glutaminase was found to be 4.09 mM whereas in 
its absence the &, of putrescine for trans- 
giutaminase was 0.06 mM with a Max of 
1.38 nmol bound/30 min per 5Opg fibronectin 
(not shown). 
The Ki of a-DFMO for ornithine decarboxylase 
is 39 pM f 13], and for transglutaminase with casein 
as substrate 2.31 mM. Therefore, inhibition of or- 
nithine carboxylase requires a 6-fold smaller dose 
of LU-DFMO than inhibition of transglutaminase. 
However, in studies using cells in culture, concen- 
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trations of 5 mM (r-DFMO are commonly used 
(6,141, and for some cell types such as 9L rat brain 
tumor cells even higher concentrations (20 mM) 
are employed [IS]. The possibility that cellular 
transglutaminase may be inhibited at such concen- 
trations cannot be ignored. 
Since cu-DFMO (Ki = 2.31 mM) is a better com- 
petitive inhibitor of transglutaminase than or- 
nithine (Ki = 12.10 mM), it would appear that the 
difluoromethyl moiety might contribute to the in- 
creased inhibition. However, when ~-~~4C]DFM0 
and [14C]ornithine were used as substrates, I& 
values of 2.1 and 1.35 mM were found, respective- 
ly. This apparent similarity in Km was not parallel- 
ed by V,, values which were 0.04 nmol 
bound/30 min per 20 pg casein in the case of a- 
DFMO and 0.53 nmol bound/30 min per 20 pg ca- 
sein in that of ornithine: i.e., 13-fold increase. 
Bound LU-DFMO may cause more structural hin- 
drance to the subsequent binding of [r4C]putres- 
tine than bound ornithine, but this is purely 
hypothetical for the moment. 
Regardless of the mechanism by which a-DFMO 
inhibits transglutaminase, its effects on this en- 
zyme may be relevant to two findings. 
(i) Animals treated with cu-DFMO show an increase 
in clotting time [7]. One interpretation of this 
result may be a direct effect of (Y-DFMO on the 
plasma transglutam~nase-fibrinogen system. 
(ii) (u-DFMO could dissociate between the or- 
nithine decarboxylase increase linked to the dif- 
ferentiation and that linked to the proliferation of 
HL60 cells induced by TPA and retinoic acid 1161. 
Since differentiation of these cells is accompanied 
by an increase in transglutaminase activity [ 171, the 
above system is being re-evaluated in the light of 
the results presented here. 
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